Centiva Capital »

Tourmaline Bio shares owned by Centiva Capital

Quarter-by-quarter ownership of Tourmaline Bio (TRML) shares owned by Centiva Capital from 13F filings

Historical chart of Centiva Capital investment in Tourmaline Bio

Tip: Access up to 7 years of quarterly data

All positions including Tourmaline Bio held by Centiva Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tourmaline Bio by Centiva Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.8M 100k 47.83

More positions owned by Centiva Capital

Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Tesla Motors (TSLA)
Regeneron Pharmaceuticals Call Option (REGN)
Pdd Holdings Sponsored Ads (PDD)
Microsoft Corporation (MSFT)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Amazon (AMZN)
Kraneshares Trust Csi Chi Internet Put Option (KWEB)
Apple Call Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)

View all positions for Centiva Capital

Top funds holding Tourmaline Bio

venBio Select Advisor
QVT Financial
BlackRock
TCG Crossover Management
Pfizer
Vanguard Group
Fil
Magnetar Financial
Qiming U.S. Ventures Management
Vivaldi Asset Management
TIG Advisors
Vivo Capital
Alliancebernstein
Highland Capital Management Fund Advisors
Geode Capital Management

View all funds holding Tourmaline Bio